Send us a text What if the way we quantify pathology is more guesswork than science? In this episode of DigiPath Digest, I take you through the latest research where AI is not just supporting but challenging traditional methods of image analysis in neuropathology, nephrology, hematology, and cytology. From Boston brain banks to Mayo Clinic kidney models, we look at how advanced AI compares to human vision—and where it already outperforms us. Episode Highlights: [00:02:49] Neuropathology image...
All content for Digital Pathology Podcast is the property of Aleksandra Zuraw, DVM, PhD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text What if the way we quantify pathology is more guesswork than science? In this episode of DigiPath Digest, I take you through the latest research where AI is not just supporting but challenging traditional methods of image analysis in neuropathology, nephrology, hematology, and cytology. From Boston brain banks to Mayo Clinic kidney models, we look at how advanced AI compares to human vision—and where it already outperforms us. Episode Highlights: [00:02:49] Neuropathology image...
144: Court Halts FDA Rule on Lab-Developed Tests: What It Means for Pathology
Digital Pathology Podcast
9 minutes
3 weeks ago
144: Court Halts FDA Rule on Lab-Developed Tests: What It Means for Pathology
Send us a text Will FDA rules disrupt the way we diagnose diseases? In this episode, I break down a seismic shift in lab medicine: a federal court has vacated the FDA’s controversial rule classifying lab-developed tests (LDTs) as medical devices. This change carries serious implications for innovation, digital pathology, AI-based diagnostics, and small labs across the U.S. 🎧 What You’ll Hear: What LDTs are and why they matter for rare diseases and personalized medicine Why the FDA rul...
Digital Pathology Podcast
Send us a text What if the way we quantify pathology is more guesswork than science? In this episode of DigiPath Digest, I take you through the latest research where AI is not just supporting but challenging traditional methods of image analysis in neuropathology, nephrology, hematology, and cytology. From Boston brain banks to Mayo Clinic kidney models, we look at how advanced AI compares to human vision—and where it already outperforms us. Episode Highlights: [00:02:49] Neuropathology image...
